Santa Clara, CA, United States of America

Debanti Sengupta

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Varian Medical Systems, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Debanti Sengupta: Innovator in Radiation Therapy

Introduction

Debanti Sengupta is a notable inventor based in Santa Clara, CA. He has made significant contributions to the field of radiation therapy, particularly through his innovative patent. His work focuses on enhancing treatment methods for patients undergoing radiation therapy.

Latest Patents

Debanti Sengupta holds a patent for "Internal dose-adapted automated external beam radiation therapy." This patent encompasses systems, devices, and methods designed for internal dose-adapted automated external radiation beam therapy. It also includes systems and methods for an automated adaptive workflow that generates a radiation treatment plan based on the internal dose. This innovation allows for the adaptation of the treatment plan to current treatment sessions using a set of directives. He has 1 patent to his name.

Career Highlights

Debanti is currently employed at Varian Medical Systems, Inc., a leading company in the field of medical technology. His role involves developing advanced solutions that improve patient outcomes in radiation therapy. His expertise and dedication have positioned him as a valuable asset in the medical technology sector.

Collaborations

Debanti collaborates with talented professionals in his field, including coworkers Luca Cozzi and Ryan Clark. Their combined efforts contribute to the advancement of innovative solutions in radiation therapy.

Conclusion

Debanti Sengupta is a pioneering inventor whose work in radiation therapy is making a significant impact on patient care. His innovative patent and contributions to Varian Medical Systems, Inc. highlight his commitment to improving treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…